AGP Executive Report
Last update: 8 hours agoDiabetes Research Under Pressure: Police removed five researchers from the American Diabetes Association meeting in New Orleans after they distributed a peer-reviewed editorial criticizing NIH budget cuts, escalating concerns about restrictions on biomedical science. Obesity & Metabolic Drug Pipeline: At ADA 2026, multiple next-gen weight-loss and diabetes candidates drew attention, including once-weekly CagriSema (amylin+GLP-1) data, survodutide’s liver-fat and visceral-fat reductions, and new results for petrelintide, berobenatide, orforglipron, and retatrutide. Diabetes Tech Gets Real-World Boost: Studies highlighted continuous glucose monitoring for non-insulin type 2 diabetes and automated insulin delivery benefits during hospitalization, plus Omnipod 6 updates aimed at improving time in range. Louisiana Coast & Flood Costs: A new Nature Water study links upstream wetland loss to higher residential flood insurance claims, with impacts noted for southeastern Louisiana. Local Science & Community: Louisiana Sea Grant and partners will host a commercial oyster workshop in Jeanerette focused on coastal habitat, workforce, and seafood markets. Public Health & Policy: The FDA is moving forward with a safety review of mifepristone, while education and faculty-support commentary continues to spotlight how learning outcomes depend on sustained teaching investment.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
